Study outcome events in patients in different risk categories according to 2014 and 2008 European Society of Cardiology (ESC) models
| Risk | ESC 2014 | ESC 2008 | |||||
| sPESI | RVD or increased troponin | Death at 30 days | Death due to pulmonary embolism | RVD or increased troponin | Death at 30 days | Death due to pulmonary embolism | |
| High# | ≥1 | 23/105 (22, 14.0–29.8) | 16/105 (15.2, 8.4–22.1) | 23/105 (22, 14.0–29.8) | 16/105 (15.2, 8.4–22.1) | ||
| Intermediate-high | ≥1 | Both present | 21/272 (7.7, 4.5–10.9) | 13/272 (4.8, 2.2–7.3) | Both present | 21/307 (6.8, 4.0–9.7) | 13/307 (4.2, 2.0–6.5) |
| Intermediate-low | ≥1 | Either present or both absent | 20/333 (6.0, 3.4–8.6) | 7/333 (2.1, 0.6–3.6) | Either present | 19/271 (7.0, 4.0–10.0) | 8/271 (3.0, 0.9–5.0) |
| Low | 0 | 1/196 (0.5, 0–1.5) | 1/196 (0.5, 0–1.5) | Both absent | 2/223 (0.9, 0–2.1) | 0/223 (–, –) | |
Data are presented as n/N (%, 95% CI). RVD: right ventricle dysfunction. #: shock or sustained hypotension.